-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PST0hh3U5qWcPDBrPpauxl/kxT0wQvRHphM2PnPC8YkqjTW/nfLFLxj5q48MCUhy 2MXHKVj3SJVuYwvvR7Q4Fg== 0001230295-08-000008.txt : 20080104 0001230295-08-000008.hdr.sgml : 20080104 20080104164852 ACCESSION NUMBER: 0001230295-08-000008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080102 FILED AS OF DATE: 20080104 DATE AS OF CHANGE: 20080104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HAYDEN BRIAN J CENTRAL INDEX KEY: 0001262224 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 08512311 BUSINESS ADDRESS: STREET 1: 1600 ASPEN COMMONS SUITE 300 CITY: MIDDLETON STATE: WI ZIP: 53562 BUSINESS PHONE: 6086627800 4 1 hay284.xml X0202 4 2008-01-02 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001262224 HAYDEN BRIAN J C/O SAVIENT PHARMACEUTICALS, INC ONE TOWER CENTER BLVD., 14TH FLOOR EAST BRUNSWICK NJ 08816 0 1 0 0 SVP, Chief Financial Officer Common Stock, $.01 par value per share 2008-01-02 4 M 0 5000 5.3300 A 36910 D Common Stock, $.01 par value per share 2008-01-02 4 S 0 5000 23.4721 D 31910 D Common Stock, $.01 par value per share 2008-01-03 4 S 0 5000 24.2572 D 26910 D Option to Purchase Common Stock, $.01 par value 5.3300 2008-01-02 4 M 0 5000 5.3300 D 2007-07-05 2016-07-05 Common Stock, $.01 par value per share 5000 125000 D This sale was made pursuant to a trading plan adopted on June 14, 2007 by the reporting person in accordance with Rule 105b-1 under the Securities Exchange Act of 1934. Represents the average sale price. The highest price at which shares were sold was $23.9401 and the lowest price at which shares were sold was $23.24. Represents the average sale price. The highest price at which shares were sold was $24.47 and the lowest price at which shares were sold was $24.07. By: /s/ Irina Azer as Attorney-In-Fact for 2008-01-04 -----END PRIVACY-ENHANCED MESSAGE-----